/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-09-23 16:08:302025-02-03 12:08:00Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-09-23 13:07:342025-02-03 12:08:00Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-09-05 12:48:122025-02-03 12:08:00Modeling the pharmacokinetics of phenylbutyrate in fed and fasted states
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-09-05 12:47:262025-02-03 12:08:00Arimoclomol for the Treatment of NPC in a Real-World Setting: Long-Term Outcomes from an Expanded Access Program in the USA
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-09-05 12:46:462025-02-03 12:08:00Arimoclomol Safety Profile in the Treatment of NPC in a Real-World Setting: Long-Term Data From an Expanded Access Program in the USA
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-09-05 12:45:372025-02-03 12:08:00Long-term Efficacy and Safety Evaluation of Arimoclomol Treatment in Patients with Niemann Pick Type C – Data from 48 Months Open Label Trial
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-09-05 12:30:152025-02-03 12:08:00Efficacy Results from a 12-month Double-blind Randomized Trial of Arimoclomol for Treatment of Niemann Pick Disease Type C – Presenting an Improved 4-Domain NPC Clinical Severity Scale
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-06-03 11:16:532025-02-03 12:08:00Safety and Efficacy of KP1077 in a Phase 2, Double-blind, Randomized Trial in Patients With Idiopathic Hypersomnia
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-06-03 11:15:102025-02-03 12:08:00Pharmacokinetics of Morning and Nighttime Doses of KP1077, an Investigational Treatment for Idiopathic Hypersomnia
/wp-content/uploads/logo.svg
0
0
Jeff Lorber
/wp-content/uploads/logo.svg
Jeff Lorber2024-06-01 14:49:212025-02-03 12:08:00A Novel Investigational Treatment for Hypersomnia: Where We Are and Where We Need to Go
Scroll to top
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settings
Cookie and Privacy Settings
